S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
Log in

NASDAQ:NOVT - Novanta Stock Price, Forecast & News

$92.23
+2.47 (+2.75 %)
(As of 12/12/2019 04:00 PM ET)
Today's Range
$89.23
Now: $92.23
$92.71
50-Day Range
$79.04
MA: $87.17
$93.61
52-Week Range
$57.07
Now: $92.23
$96.31
Volume223,674 shs
Average Volume151,892 shs
Market Capitalization$3.23 billion
P/E Ratio42.70
Dividend YieldN/A
Beta1.48
Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. Read More…

Industry, Sector and Symbol

Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:NOVT
Previous SymbolNASDAQ:GSIG
CUSIPN/A
Phone781-266-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$614.34 million
Cash Flow$3.42 per share
Book Value$10.55 per share

Profitability

Net Income$49.11 million

Miscellaneous

Employees2,133
Market Cap$3.23 billion
Next Earnings Date2/26/2020 (Estimated)
OptionableOptionable

Receive NOVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NOVT and its competitors with MarketBeat's FREE daily newsletter.


Novanta (NASDAQ:NOVT) Frequently Asked Questions

What is Novanta's stock symbol?

Novanta trades on the NASDAQ under the ticker symbol "NOVT."

How were Novanta's earnings last quarter?

Novanta Inc (NASDAQ:NOVT) issued its quarterly earnings results on Tuesday, November, 5th. The technology company reported $0.53 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.52 by $0.01. The technology company earned $154.10 million during the quarter, compared to the consensus estimate of $155.04 million. Novanta had a net margin of 6.94% and a return on equity of 20.01%. Novanta's revenue was down 4.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.61 EPS. View Novanta's Earnings History.

When is Novanta's next earnings date?

Novanta is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for Novanta.

What guidance has Novanta issued on next quarter's earnings?

Novanta issued an update on its fourth quarter earnings guidance on Tuesday, November, 5th. The company provided earnings per share (EPS) guidance of $0.52-$0.54 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.62. The company issued revenue guidance of $156-$158 million, compared to the consensus revenue estimate of $167.28 million.

What price target have analysts set for NOVT?

1 equities research analysts have issued 1-year target prices for Novanta's shares. Their forecasts range from $81.00 to $81.00. On average, they anticipate Novanta's stock price to reach $81.00 in the next year. This suggests that the stock has a possible downside of 12.2%. View Analyst Price Targets for Novanta.

What is the consensus analysts' recommendation for Novanta?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Novanta.

Has Novanta been receiving favorable news coverage?

Headlines about NOVT stock have trended extremely negative on Thursday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Novanta earned a news impact score of -5.0 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Novanta.

Are investors shorting Novanta?

Novanta saw a increase in short interest in the month of November. As of November 29th, there was short interest totalling 674,200 shares, an increase of 10.7% from the November 14th total of 609,100 shares. Based on an average daily trading volume, of 145,700 shares, the short-interest ratio is currently 4.6 days. Currently, 2.0% of the company's stock are short sold. View Novanta's Current Options Chain.

Who are some of Novanta's key competitors?

What other stocks do shareholders of Novanta own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Novanta investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intuitive Surgical (ISRG), Broadcom (AVGO), Netflix (NFLX), Arista Networks (ANET), GrubHub (GRUB), Palo Alto Networks (PANW), Splunk (SPLK) and Weibo (WB).

Who are Novanta's key executives?

Novanta's management team includes the folowing people:
  • Mr. Matthijs Glastra, CEO & Director (Age 50)
  • Mr. Robert J. Buckley, Chief Financial Officer (Age 45)
  • Mr. Brian S. Young, Chief HR Officer (Age 50)
  • Mr. Peter L. Chang, VP, Corp. Controller & Chief Accounting Officer (Age 54)
  • Mr. Heinrich Dreyer, Group Pres of Minimally Invasive Surgery

Who are Novanta's major shareholders?

Novanta's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (2.30%), Paradice Investment Management LLC (2.02%), State Street Corp (1.97%), GW&K Investment Management LLC (0.68%), Stifel Financial Corp (0.49%) and Norris Perne & French LLP MI (0.33%). Company insiders that own Novanta stock include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Institutional Ownership Trends for Novanta.

Which institutional investors are selling Novanta stock?

NOVT stock was sold by a variety of institutional investors in the last quarter, including Stifel Financial Corp, Sandler Capital Management, Essex Investment Management Co. LLC, Bradley Foster & Sargent Inc. CT, Barclays PLC, Skylands Capital LLC, Penserra Capital Management LLC and Strs Ohio. Company insiders that have sold Novanta company stock in the last year include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Insider Buying and Selling for Novanta.

Which institutional investors are buying Novanta stock?

NOVT stock was acquired by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, GW&K Investment Management LLC, Congress Asset Management Co. MA, California Public Employees Retirement System, Comerica Bank, Paradice Investment Management LLC, State Street Corp and Norris Perne & French LLP MI. View Insider Buying and Selling for Novanta.

How do I buy shares of Novanta?

Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Novanta's stock price today?

One share of NOVT stock can currently be purchased for approximately $92.23.

How big of a company is Novanta?

Novanta has a market capitalization of $3.23 billion and generates $614.34 million in revenue each year. The technology company earns $49.11 million in net income (profit) each year or $2.16 on an earnings per share basis. Novanta employs 2,133 workers across the globe.View Additional Information About Novanta.

What is Novanta's official website?

The official website for Novanta is http://www.novanta.com/.

How can I contact Novanta?

Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company can be reached via phone at 781-266-5700 or via email at [email protected]


MarketBeat Community Rating for Novanta (NASDAQ NOVT)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  239 (Vote Outperform)
Underperform Votes:  172 (Vote Underperform)
Total Votes:  411
MarketBeat's community ratings are surveys of what our community members think about Novanta and other stocks. Vote "Outperform" if you believe NOVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NOVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Featured Article: What is an economic bubble?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel